Market Overview

Opportunities in the Global Psoriasis Therapeutics Market to 2026 - Player Profiles for J&J, Novartis, Merck, Janssen, Eli Lilly and Co, Eisai, Celgene, BMS, and more -


The "Psoriasis
Therapeutics - Global Market Outlook (2017-2026)"
report has
been added to's offering.

According to the report, the Global Psoriasis Therapeutics market is
expected to grow at a CAGR of 10.5% during the forecast period.

Availability of new diagnostic procedures, growing preference for
combination therapies, increasing awareness about treatment, rising
demand for improved healthcare infrastructure and changing lifestyle of
people are some factors influencing the market growth.

Further, better diagnostic tools availablity for psoriasis will result
in increasing the treatmento seeking patient population which in turn
boost the market's growth prospects in the coming years.

Depending on molecule, the biologics segment dominated the market. The
growth of this segment is also attributed the launch of novel biologics
like Cosentyx by Novartis.

By geography, North America dominated the global market due to the
established healthcare infrastructure, high adoption of therapeutics and
presence of key manufacturers in the U.S. Moreover, increasing
prevalence and favorable government initiatives are some drivers fueling
the market growth.

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porter's Five Forces Analysis

5 Global Psoriasis Therapeutics Market, By Dosage Form

6 Global Psoriasis Therapeutics Market, By Molecule

7 Global Psoriasis Therapeutics Market, By Mechanism of Action

8 Global Psoriasis Therapeutics Market, By Route of Administration

9 Global Psoriasis Therapeutics Market, By Distribution Channel

10 Global Psoriasis Therapeutics Market, By Geography

11 Key Developments

12 Company Profiling

  • Johnson & Johnson
  • Novartis AG
  • Merck & Co. Inc.
  • Janssen Biotech Inc.
  • Incyte Corp.
  • Eli Lilly and Company
  • Eisai Co. Ltd.
  • Celgene Corporation
  • Bristol Myers Squibb Co.
  • AstraZeneca
  • Amgen Inc.
  • AbbVie Inc.
  • LEO Pharma A/S
  • UCB S.A.
  • Pfizer Inc.

For more information about this report visit

View Comments and Join the Discussion!